{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:16:41Z","timestamp":1790741801217,"version":"4.1.0"},"reference-count":140,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T00:00:00Z","timestamp":1767484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Drug Development Research"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>The epidermal growth factor receptor (EGFR) is a key target in cancer therapy, mainly in non\u2010small cell lung cancer (NSCLC). Though, the efficacy of EGFR\u2010targeted therapies is limited by the development of resistance. This comprehensive review details the structural biology of EGFR and its role in oncogenic signaling, elucidating the major activating mutations, particularly exon 19 deletions and L858R point mutations, and acquired resistance. The progressive development of EGFR tyrosine kinase inhibitors (TKIs), from first\u2010generation ATP\u2010competitive inhibitors (e.g., gefitinib, erlotinib) to third\u2010generation covalent agents (e.g., osimertinib) and emerging fourth\u2010generation allosteric and degradation approaches, are critically examined for their mechanisms, efficacy, and clinical limitations. We have also discussed about the intrinsic and acquired resistance mechanisms, including alternative oncogenic drivers (KRAS, ALK), bypass pathway activations (MET, HER2), and phenotypic changes like epithelial\u2010mesenchymal transition. Additionally, we emphasize the role of computational modeling, high\u2010throughput SAR studies, and preclinical models, including patient\u2010derived xenografts and organoids, in guiding rational drug design. Emerging approaches integrating artificial intelligence, machine learning, and precision oncology hold potential to accelerate EGFR\u2010targeted drug discovery. The combination strategies with immunotherapy, and anti\u2010angiogenic agents are considered in the context of improving patient outcomes. Together, ongoing advances in understanding EGFR signaling and resistance mechanisms are driving the development of next\u2010generation inhibitors and personalized therapies, with the ultimate goal of overcoming drug resistance and improve patient outcomes in EGFR\u2010mutant cancers.<\/jats:p>","DOI":"10.1002\/ddr.70220","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T05:17:40Z","timestamp":1767590260000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Overcoming Resistance in EGFR\u2010Mutant Cancers: A Comprehensive Review of Inhibitor Evolution and SAR\u2010Based Design"],"prefix":"10.1002","volume":"87","author":[{"given":"Hemlata","family":"Naykwadi","sequence":"first","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy &amp; Technology Management, SVKM's NMIMS, V.L. Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajasekhar Reddy","family":"Alavala","sequence":"additional","affiliation":[{"name":"Shobhaben Pratapbhai Patel School of Pharmacy &amp; Technology Management, SVKM's NMIMS, V.L. Mumbai Maharashtra India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,1,4]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1039\/C9CS00720B"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102985"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42250-023-00592-9"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103726"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27030819"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30407-3"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdz394.066"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00894-023-05531-6"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15205079"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.47760\/ijpsm.2024.v09i09.001"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1746269"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1063\/5.0157367"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1039\/C7MD90012K"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells3020199"},{"key":"e_1_2_11_16_1","unstructured":"Catherine P. 2019 Targeting Cell Intrinsic and Extrinsic Mechanisms Involved in the Initiation and Maintenance of Non\u2010Small Cell Lung Cancer PhD diss. University of Colorado Anschutz."},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.12.067"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11815"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2021-0205"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm201591k"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.240"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jpcb.8b02040"},{"key":"e_1_2_11_23_1","doi-asserted-by":"crossref","unstructured":"Chen H. R.Bird D.Wang et al. A Perspective on Covalent Inhibitors: Research and Development Trends of Warheads and Targets2023.https:\/\/doi.org\/10.26434\/chemrxiv-2023-wf79n-v2.","DOI":"10.26434\/chemrxiv-2023-wf79n-v2"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S66502"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867323666160510123604"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312828"},{"key":"e_1_2_11_27_1","unstructured":"CORRECTED NDA APPROVAL.US FOOD & DRUG n.d.https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents(Accessed November 20 2025)."},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15545"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-biochem-090308-173656"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1039\/D4MD00384E"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08989"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1885"},{"key":"e_1_2_11_33_1","unstructured":"FDA. Grants Accelerated Approval to Mobocertinib for Metastatic Non\u2010Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations. US FOOD & DRUG 2021.https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-grants-accelerated-approval-mobocertinib-metastatic-non-small-cell-lung-cancer-egfr-exon-20?utm(Accessed November 19 2025)."},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs-2018-0038"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30230-0"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1331062"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00934"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10060155"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15030841"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-021-00563-7"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30934-X"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.598877"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e11537"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12040927"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.1177\/2472555218787445"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3RA05401B"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520623666230227153449"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5c00326"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.2c00213"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.05.015"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.202100270"},{"key":"e_1_2_11_53_1","doi-asserted-by":"publisher","DOI":"10.3390\/genes13040653"},{"key":"e_1_2_11_54_1","unstructured":"Important Information About EXKIVITY\u00ae (mobocertinib). Takeda Pharmaceuticals USA 2024.https:\/\/www.exkivity-update.com\/?utm(Accessed November 19 2025)."},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.09.985"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2014.257"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-20-0229"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp097"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1169"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11101480"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2018.9"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cdc.2022.100851"},{"key":"e_1_2_11_63_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2014-0089"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28566"},{"key":"e_1_2_11_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201458"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14143337"},{"key":"e_1_2_11_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giz044"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1542"},{"key":"e_1_2_11_69_1","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24-603"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3773"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01419-2"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242316761"},{"key":"e_1_2_11_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/10799893.2019.1683865"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202300562"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.2c01242"},{"key":"e_1_2_11_76_1","doi-asserted-by":"crossref","unstructured":"Maji D.Discovery of Novel EGFR Kinase Inhibitors Using a Wild\u2010Type EGFR: A Computational Approach2025.https:\/\/doi.org\/10.26434\/chemrxiv-2025-k329j.","DOI":"10.26434\/chemrxiv-2025-k329j"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.1039\/D3RA02347H"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040316"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520620666200721102726"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10755"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0027"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0337-2"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-18-1281"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscs.2011.04.017"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.9734\/jcti\/2025\/v15i2294"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-802220-7.00005-3"},{"key":"e_1_2_11_87_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S242045"},{"key":"e_1_2_11_88_1","doi-asserted-by":"publisher","DOI":"10.15252\/embr.201439949"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.5b01221"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20121513"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.05.027"},{"key":"e_1_2_11_92_1","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1734092"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.6b00482"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1109\/TCBB.2022.3141697"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_242209"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297920090011"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers7020816"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-84217-2"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.3109\/14756366.2013.765417"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-023-00921-6"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040534"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070923"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13065-019-0632-5"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2020.08.1610"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)00114-8"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809615"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00515-0"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21635"},{"key":"e_1_2_11_109_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2006.06.001"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells13010047"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.10.051"},{"key":"e_1_2_11_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2023.101160"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers10090335"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557516666160804162457"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.188967"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6468(08)70281-9"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2016.00076"},{"key":"e_1_2_11_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep24817"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1403438111"},{"key":"e_1_2_11_121_1","doi-asserted-by":"publisher","DOI":"10.1145\/3626772.3657775"},{"key":"e_1_2_11_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae338"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6604559"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0903"},{"key":"e_1_2_11_125_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c00927"},{"key":"e_1_2_11_126_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1251102"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm040159c"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112748"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep33949"},{"key":"e_1_2_11_130_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.568059"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.1080\/17568919.2024.2389764"},{"key":"e_1_2_11_132_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-016-0488-1"},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.2174\/1568026618666180813152921"},{"key":"e_1_2_11_134_1","unstructured":"Withdrawn|Cancer Accelerated Approvals. US FOOD & DRUG2024.https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/withdrawn-cancer-accelerated-approvals?utm(Accessed November 19 2025)."},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3720"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114900"},{"key":"e_1_2_11_137_1","doi-asserted-by":"publisher","DOI":"10.1051\/e3sconf\/202455304013"},{"key":"e_1_2_11_138_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113491"},{"key":"e_1_2_11_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105420"},{"key":"e_1_2_11_140_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.1c01977"},{"key":"e_1_2_11_141_1","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4649191"}],"container-title":["Drug Development Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.70220","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ddr.70220","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ddr.70220","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:56:45Z","timestamp":1769853405000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/ddr.70220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":140,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.1002\/ddr.70220"],"URL":"https:\/\/doi.org\/10.1002\/ddr.70220","archive":["Portico"],"relation":{},"ISSN":["0272-4391","1098-2299"],"issn-type":[{"value":"0272-4391","type":"print"},{"value":"1098-2299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,4]]},"assertion":[{"value":"2025-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70220"}}